TMCnet38m
Kirby McInerney LLP Reminds Humacyte (HUMA) Investors of Class Action Filing and Encourages Investors to Contact the Firm
The law firm of Kirby McInerney LLP reminds investors that a class action lawsuit has been filed in the U.S. District Court for the North Carolina Middle District on behalf of those who acquired ...
Humacyte’S (HUMA) Statements To Investors Called Into Question In Light Of FDA Violations – Hagens Berman
“The allegations in the complaint highlight serious violations of securities laws. If proven true, Humacyte's alleged failure to disclose material information to investors is unacceptable,” said Reed ...
manilatimes9h
Silynxcom Enhancing Drone Sound Awareness for Armored Vehicle Crews with Upgraded New Product
Silynxcom's new APC headset integrates advanced auditory technology to allow for hearing protection from continuous and ...
Humacyte to Present at the Piper Sandler 36th Annual Healthcare Conference
Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable, bioengineered human tissue at commercial scale, today announced that Laura Niklason, ...
Business Wire22h
HUMA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Humacyte, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Act…
Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has be ...
Humacyte, Inc. Is Being Sued For Violating Securities Regulations And Impacted Investors Should Assist The Schall Law Firm
LOS ANGELES, CA / ACCESSWIRE / December 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a ...
Macau Business2d
ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Humacyte, Inc. Investors to Secure Counsel Before...
Class Action, Consumer Services, GlobeNewswire, Law & Legal Issues | NEW YORK, Nov. 30, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law F ...
bovnews2d
What’s Causing Humacyte Inc (HUMA) Stock’s -40.24% Drop Over the Last Six Months?
On Friday, Humacyte Inc (HUMA) stock saw a modest uptick, ending the day at $4.47 which represents a slight increase of $0.07 or 1.59% from the prior close of $4.4. The stock opened at $4.44 and ...
The Schall Law Firm Encourages Shareholders With Losses To Join A Fraud Case Against Humacyte Inc
Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press ...
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Humacyte
If you suffered losses exceeding $75,000 in Humacyte between May 10, 2024 and October 17, 2024 and would like to discuss your ...
Humacyte, Inc. (NASDAQ:HUMA) Given Consensus Recommendation of “Buy” by Brokerages
Humacyte, Inc. (NASDAQ:HUMA – Get Free Report) has been assigned a consensus rating of “Buy” from the eight research firms ...
Insider Buyers At Humacyte Likely Disappointed With 17% Slide
Insiders who acquired US$775.1k worth of Humacyte, Inc.'s ( NASDAQ:HUMA ) stock at an average price of US$6.64 in ...